<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
Cardiomyopathies are a heterogeneous group of diseases of the myocardium that represent a major cause of morbidity and mortality due to progressive heart failure or sudden death. Cardiac resynchronization therapy has become an essential therapeutic tool in the treatment of heart failure patients today. It is an optimal choice in patients with dilated cardiomyopathy; however, its role in the management of patients with other forms of cardiomyopathies is still under investigation. This article discusses the most recent evidence for the use of cardiac resynchronization therapy in cardiomyopathies.
Cardiac Resynchronization Therapy, Cardiomyopathy, Dilated, Heart Failure, Treatment Outcome, Humans, Cardiomyopathy, Hypertrophic
Cardiac Resynchronization Therapy, Cardiomyopathy, Dilated, Heart Failure, Treatment Outcome, Humans, Cardiomyopathy, Hypertrophic
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 3 | |
popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |